Mesoblast Limited Share Price
Stocks
MSB
AU000000MSB8
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:10 11/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.030 AUD | -2.40% |
|
-3.33% | -25.37% |
| 10/11 | Mesoblast Expands Operational Management to Prepare for Commercial Launch, Names Interim COO | MT |
| 02/11 | Mesoblast Limited Announces Board and Committee Changes | CI |
| Market Cap | 270.1Cr 184.97Cr 165.88Cr 152.88Cr 138.84Cr 262.76Cr 17TCr 1.83TCr 729.31Cr 9.29TCr 694.19Cr 679.46Cr 29TCr | P/E 2027 * |
-57.2x | P/E 2028 * | 101x |
|---|---|---|---|---|---|
| Enterprise Value | 280.5Cr 192.1Cr 172.28Cr 158.77Cr 144.19Cr 272.89Cr 18TCr 1.9TCr 757.41Cr 9.65TCr 720.93Cr 705.64Cr 31TCr | EV / Sales 2027 * |
11.4x | EV / Sales 2028 * | 7.77x |
| Free-Float |
63.36% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| MSB | Delayed | |
OTC Markets
| MEOBF | Delayed | |
|
Tradegate
| LWB | Real-time | |
|
Boerse Muenchen
| LWB | Real-time | |
|
Deutsche Boerse AG
| LWB | Delayed | |
|
Börse Stuttgart
| LWB | Delayed | |
|
Berne S.E.
| LWB | End-of-day quote |
Last Transcript: Mesoblast Limited
| 1 day | -2.40% | ||
| 1 week | -3.33% | ||
| Current month | -10.18% | ||
| 1 month | -1.46% | ||
| 3 months | -15.77% | ||
| 6 months | +1.50% | ||
| Current year | -25.37% |
| 1 week | 2.02 |  | 2.2 |
| 1 month | 1.74 | | 2.38 |
| Current year | 1.74 | | 3.31 |
| 1 year | 1.74 | | 3.31 |
| 3 years | 0.26 | | 3.37 |
| 5 years | 0.26 | | 3.37 |
| 10 years | 0.26 | | 5.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
CEO | Chief Executive Officer | 69 | 23/03/2011 |
James O'Brien
DFI | Director of Finance/CFO | 59 | 17/11/2025 |
Teresa Montagut
CTO | Chief Tech/Sci/R&D Officer | - | 11/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
BRD | Director/Board Member | 69 | 01/01/2007 |
Eric Rose
BRD | Director/Board Member | 75 | 15/04/2013 |
William Burns
BRD | Director/Board Member | 79 | 06/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/08/26 | Free | Director | 8,75,000 | 0.0674% | ||
| 17/07/26 | Exercice | Founder | 18,85,334 | 0.1456% | ||
| 17/07/26 | Exercice | Founder | -18,85,334 | 0.1456% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.40% | -3.33% | -12.12% | +463.89% | 184.97Cr | |
| +0.01% | +11.10% | +60.83% | +70.43% | 6.83TCr | |
| +1.22% | +9.56% | +15.97% | +90.23% | 6.03TCr | |
| +0.24% | +1.35% | +23.78% | +97.55% | 5.59TCr | |
| +1.60% | +19.44% | +28.80% | +112.95% | 4.84TCr | |
| -1.32% | +4.78% | +29.15% | +40.40% | 4.53TCr | |
| -3.54% | -0.60% | +207.76% | +879.50% | 4.18TCr | |
| -3.33% | +6.90% | +22.78% | +48.07% | 3.45TCr | |
| -2.19% | -3.71% | +90.94% | +66.33% | 3.38TCr | |
| -1.77% | +0.83% | +46.57% | -0.16% | 2.6TCr | |
| Average | -1.15% | +4.48% | +51.45% | +186.92% | 4TCr | |
| Weighted average by Cap. | -0.68% | +5.21% | +55.00% | +154.97% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 25Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.57TCr 166.21Cr 66Cr 843.71Cr 63Cr 62Cr 2.67TCr | 37Cr 25Cr 22Cr 21Cr 19Cr 36Cr 2.35TCr 248.13Cr 99Cr 1.26TCr 94Cr 92Cr 3.98TCr |
| Net income | -3.44Cr -2.35Cr -2.11Cr -1.94Cr -1.77Cr -3.34Cr -220.58Cr -23Cr -9.28Cr -118.18Cr -8.83Cr -8.64Cr -373.59Cr | 5.69Cr 3.9Cr 3.49Cr 3.22Cr 2.92Cr 5.53Cr 365.31Cr 39Cr 15Cr 195.72Cr 15Cr 14Cr 618.73Cr |
| Net Debt | 10Cr 7.13Cr 6.39Cr 5.89Cr 5.35Cr 10Cr 668.18Cr 71Cr 28Cr 357.99Cr 27Cr 26Cr 1.13TCr | 14Cr 9.8Cr 8.79Cr 8.1Cr 7.36Cr 14Cr 918.74Cr 97Cr 39Cr 492.23Cr 37Cr 36Cr 1.56TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | A$2.030 | -2.40% | 15,87,374 |
| 10/26/10 | A$2.080 | +1.96% | 26,58,570 |
| 09/26/09 | A$2.040 | +0.49% | 23,10,883 |
| 06/26/06 | A$2.030 | -6.45% | 25,48,051 |
| 05/26/05 | A$2.170 | +3.33% | 32,73,099 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MSB Stock
Select your edition
All financial news and data tailored to specific country editions
